Ganga Pharmaceuticals Ltd vs Mono Pharmacare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Ganga Pharmaceuticals Ltd is ₹ 12 as of 12 Feb 15:30 . The P/E Ratio of Ganga Pharmaceuticals Ltd is 0 as of March 2023 .The P/E Ratio of Mono Pharmacare Ltd is 0 as of March 2023 . The Market Cap of Ganga Pharmaceuticals Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Mono Pharmacare Ltd is ₹ 0 crore as of March 2023 . The Revenue of Ganga Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Mono Pharmacare Ltd is ₹ 0 crore as of Jun '24 . The EBITDA of Ganga Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Mono Pharmacare Ltd is ₹ 0 crore as of Jun '24 . The Net Profit of Ganga Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Mono Pharmacare Ltd is ₹ 0 crore as of Jun '24 . The Dividend Payout of Ganga Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Mono Pharmacare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Ganga Pharmaceuticals Ltd

Ganga Pharmaceuticals Ltd was incorporated as a Public Limited Company in Aug.'94 and promoted by Brij Mohan Sharma. he Company is engaged in the business of manufacturing & trading in Pharmaceuticals & allied products (Ayurveda). In Apr.'95, the company took over Ganga pharmaceuticals, a proprietory concern (owned by the same promoter), which was manufacturing and marketing ayurvedic products since the last two decades. The company which manufactures ayurvedic medicines, started commercial production in Apr.'95.
In Jul.'96, it came out with a public issue to part-finance the expansion programme involving setting up of a new manufacturing unit for the manufacture of ayurvedic medicines at Murbad, Maharashtra. The company which commenced exports in Jan.'96, has marketing arrangements with parties located in Saudi Arabia, Dubai, Italy, Romania and Russia to market its products in their respective regions.

About Mono Pharmacare Ltd

Mono Pharmacare Limited was originally formed as a Partnership Firm in the name and style of 'M/s.
Mono Chemist' through Partnership Deed dated May 06, 1994.
The Partnership Firm was then converted into Public Limited company in the name of Mono Pharmacare Limited vide Certificate of Incorporation dated October 17, 2022, was issued by the Registrar of Companies, Ahmedabad.
The Company is engaged in the business of marketing and distribution of pharmaceutical products. The product portfolio comprises of a wide range of drugs like Antibiotics, Antifungal, Anti CoughCold & Anti-allergic, Antacid and Antiemetics, Analgesics and Antipyretics, Nutraceuticals, Skincare, Antiseptic, Cardiac and Diabetic & Cosmetics etc. getting products manufactured through contract manufacturing. Supal Distributors LLP, a Partnership Firm, was incorporated on November 24, 2016, with the Promoters of Company, Panilam Lakhatariya and Supal Lakhatariya, being the Original Partners.

FAQs for the comparison of Ganga Pharmaceuticals Ltd and Mono Pharmacare Ltd

Which company has a larger market capitalization, Ganga Pharmaceuticals Ltd or Mono Pharmacare Ltd?

Market cap of Ganga Pharmaceuticals Ltd is 7 Cr while Market cap of Mono Pharmacare Ltd is 23 Cr

What are the key factors driving the stock performance of Ganga Pharmaceuticals Ltd and Mono Pharmacare Ltd?

The stock performance of Ganga Pharmaceuticals Ltd and Mono Pharmacare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ganga Pharmaceuticals Ltd and Mono Pharmacare Ltd?

As of May 4, 2026, the Ganga Pharmaceuticals Ltd stock price is INR ₹12.0. On the other hand, Mono Pharmacare Ltd stock price is INR ₹13.25.

How do dividend payouts of Ganga Pharmaceuticals Ltd and Mono Pharmacare Ltd compare?

To compare the dividend payouts of Ganga Pharmaceuticals Ltd and Mono Pharmacare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.